Table 3 Improvement of symptoms as measured by the SIGH-SAD, HAMA, and BDI
Improvement | Group 1 (n = 28) | Group 2 (n = 31) | Group 3 (n = 30) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | % | 95% CI | p-value | % | 95% CI | p-value | % | 95% CI | p-value |
SIGH-SAD | 47.4 | 34.9-60.0 | 0.0001 | 45.9 | 36.0-55.7 | 0.0001 | 43.7 | 32.7-54.8 | 0.0001 |
HAMA | 49.9 | 34.7-65.2 | 0.0137 | 49.5 | 38.5-60.5 | 0.0056 | 46.5 | 35.9-57.2 | 0.0001 |
BDI | 67.3 | 53.0-81.6 | 0.0158 | 67.4 | 55.5-79.4 | 0.1282 | 63.2 | 49.9-76.6 | 0.0013 |